Issue link: https://www.e-digitaleditions.com/i/1056686
Information from companies that provide capsule-and-blister-related products and services that may be useful in research and development or manufacturing. Content is provided by companies, with no preference intended. 10 December 2018 Inhalation Special Section capSuleS/BliSterS This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the organizations listed. No endorsement or preference is intended. Bioperformance of inhaled therapeutics Strong bioperformance of your inhaled therapeutics is key to realizing optimal patient outcomes. Lonza sup- ports you in optimizing performance by leveraging unique capabilities and expertise in product design and particle engineering. You gain access to a large array of specialized tools, including micronization, spray-dry processing and nanocrystal technologies. Combined with formulation expertise for both small and large molecules, specialized DPI capsules and finished prod- uct manufacturing capabilities to commercial scale, we bring your product from concept to market. Lonza–Capsugel US: +1 888 783-6361 www.pharma.lonza.com Hypromellose capsules for DPIs Quali-V ® hypromellose capsules from Qualicaps have a low moisture content (4.5-6.5%) for improved sta- bility with no brittleness, even when the moisture con- tent falls below 4.5%. ese two-piece capsules exhibit good puncturing and cutting characteristics for DPI applications, with fewer shell particles compared to gelatin capsules. Quali-V capsules are less susceptible to static buildup, so less powder clings to the capsule surface during inspiration. e capsules, from a non- animal source, are kosher- and halal-certified and com- ply with all pharmacopoeial requirements for USP, EurPh and JP. Qualicaps US: +1 800-CAPSULE www.qualicaps.com